新聞中心及演示文稿
上一篇文章   |   下一篇文章
創新平台, 監管信息公告 | 2007-11-22

Chi-Med Plans to Initiate Global Phase IIb Trials of its Lead Anti-Inflammatory Drug Candidate, HMPL-004, in Ulcerative Colitis Patients